BRIEF published on 09/28/2026 at 14:40, 13 days 6 hours ago Advicenne publishes its monthly voting rights figures Share Capital Voting Rights AMF Share Issuance Advicenna
BRIEF published on 09/28/2026 at 14:40, 13 days 6 hours ago Advicenne publie ses chiffres mensuels de droits de vote Droits De Vote Capital Social AMF Émission D'actions Advicenne
PRESS RELEASE published on 09/28/2026 at 14:35, 13 days 6 hours ago Informations privilégiées / Autres communiqués ADVICENNE publie le nombre total de droits de vote et d'actions composant son capital social conformément aux réglementations en vigueur Euronext Growth Paris Droits De Vote Capital Social AMF Advicenne
BRIEF published on 08/31/2026 at 07:05, 1 month 11 days ago Advicenne withdraws the application for registration of ADV7103 in the United States FDA Pharmaceutical Registration Advicenna Sibnayal
BRIEF published on 08/31/2026 at 07:05, 1 month 11 days ago Advicenne retire la demande d'enregistrement d'ADV7103 aux États-Unis FDA Pharmaceutique Advicenne Sibnayal Enregistrement
PRESS RELEASE published on 08/31/2026 at 07:00, 1 month 11 days ago Inside Information / Other news releases Advicenne voluntarily withdraws NDA for ADV7103 in the USA due to CMC-related work issues. Company hosting French webinar for shareholders. ADV7103 approved in EU, UK, KSA, UAE Pharmaceutical Webinar Advicenne ADV7103 NDA Withdrawal
PRESS RELEASE published on 08/31/2026 at 07:00, 1 month 11 days ago Informations privilégiées / Autres communiqués Advicenne retire la demande d'enregistrement de ADV7103 aux Etats-Unis pour le traitement de l'Acidose Tubulaire Rénale distale primaire, en raison de travaux complémentaires requis dans le domaine CMC Advicenne Retrait ADV7103 Acidose Tubulaire Rénale Demande D'enregistrement
BRIEF published on 07/16/2026 at 18:40, 2 months 26 days ago Forte hausse du chiffre d'affaires d'Advicenne au premier semestre 2026 Croissance Des Revenus Advicenne Sibnayal® Likozam® Ventes Pharmaceutiques
BRIEF published on 07/16/2026 at 18:40, 2 months 26 days ago Advicenne's Revenue Surge in First Half of 2026 Revenue Growth Advicenne Sibnayal® Likozam® Pharmaceutical Sales
PRESS RELEASE published on 07/16/2026 at 18:35, 2 months 26 days ago Inside Information / Other news releases Advicenne reports significant revenue growth in first half of 2026 driven by Sibnayal® and Likozam® reimbursement in France, ending negative impact of early access rebates. Sales of Sibnayal® and Likozam® increased in volume Revenue Growth France Advicenne Sibnayal® Likozam®
Published on 10/10/2026 at 04:45, 1 day 16 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 1 day 18 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 1 day 18 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 1 day 21 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 1 day 22 hours ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 16:35, 1 day 4 hours ago New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Published on 10/10/2026 at 16:30, 1 day 4 hours ago ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Published on 10/10/2026 at 10:05, 1 day 10 hours ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 1 day 23 hours ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 1 day 23 hours ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:27, 2 days 1 hour ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 2 days 1 hour ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 2 days 3 hours ago Déclaration des droits de vote à fin septembre 2026
